Novartis
NVS
NVS
1,338 hedge funds and large institutions have $15.4B invested in Novartis in 2025 Q1 according to their latest regulatory filings, with 121 funds opening new positions, 424 increasing their positions, 501 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,338
Holders Change
+11
Holders Change %
+0.83%
% of All Funds
18.17%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.19%
New
121
Increased
424
Reduced
501
Closed
79
Calls
$246M
Puts
$281M
Net Calls
-$34.8M
Net Calls Change
+$25.5M
Top Buyers
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$531M |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$202M |
| 3 |
Goldman Sachs
New York
|
+$154M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$150M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$121M |
